评价-话题@MedSci

#评价#

750篇内容 | 2987人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1444432, encodeId=6de51444432eb, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=JAHA：轻度肺动脉高压与死亡率升高相关：系统评价和meta分析, objectType=article, longId=149132, objectId=1d5e14913255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d5e14913255, replyNumber=0, likeNumber=59, createdTime=2018-09-21, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d5e14913255, moduleTitle=JAHA：轻度肺动脉高压与死亡率升高相关：系统评价和meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d5e14913255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444431, encodeId=f24b14444310a, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=关于非临床安全评价中药物未出现明显毒性的考虑, objectType=article, longId=148615, objectId=45a4148615ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45a4148615ae, replyNumber=0, likeNumber=50, createdTime=2018-09-12, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45a4148615ae, moduleTitle=关于非临床安全评价中药物未出现明显毒性的考虑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45a4148615ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444430, encodeId=4635144443039, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=又有7个药通过一致性评价，大洗牌来了, objectType=article, longId=148561, objectId=cda6148561d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda6148561d3, replyNumber=0, likeNumber=0, createdTime=2018-09-11, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda6148561d3, moduleTitle=又有7个药通过一致性评价，大洗牌来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda6148561d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444429, encodeId=e45114444295d, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=基药目录调入调出仿制药直面一致性评价大洗牌, objectType=article, longId=148392, objectId=5c491483925c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c491483925c, replyNumber=0, likeNumber=52, createdTime=2018-09-09, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c491483925c, moduleTitle=基药目录调入调出仿制药直面一致性评价大洗牌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c491483925c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444428, encodeId=f327144442867, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=定了！289品种年底未通过一致性评价直接淘汰！, objectType=article, longId=148278, objectId=7baf1482e8d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7baf1482e8d3, replyNumber=0, likeNumber=69, createdTime=2018-09-07, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7baf1482e8d3, moduleTitle=定了！289品种年底未通过一致性评价直接淘汰！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7baf1482e8d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444427, encodeId=49f7144442edf, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=一致性评价后医药市场格局, objectType=article, longId=148110, objectId=1df514811051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1df514811051, replyNumber=0, likeNumber=48, createdTime=2018-09-05, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1df514811051, moduleTitle=一致性评价后医药市场格局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1df514811051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444426, encodeId=02d51444426e1, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=重磅！《医疗器械不良事件监测和再评价管理办法》发布, objectType=article, longId=147986, objectId=26e914e98608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26e914e98608, replyNumber=0, likeNumber=77, createdTime=2018-09-02, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26e914e98608, moduleTitle=重磅！《医疗器械不良事件监测和再评价管理办法》发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26e914e98608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444425, encodeId=198f1444425da, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=又一省，一致性评价药品特权落地, objectType=article, longId=147700, objectId=0b6314e7003f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b6314e7003f, replyNumber=0, likeNumber=57, createdTime=2018-08-31, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b6314e7003f, moduleTitle=又一省，一致性评价药品特权落地, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b6314e7003f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444424, encodeId=8416144442472, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=又一省一致性评价药品特权落地, objectType=article, longId=147678, objectId=f5aa14e6785e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5aa14e6785e, replyNumber=0, likeNumber=0, createdTime=2018-08-31, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5aa14e6785e, moduleTitle=又一省一致性评价药品特权落地, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5aa14e6785e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444423, encodeId=1f8714444236b, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=未过一致性评价均不再采购千家药企受影响, objectType=article, longId=147415, objectId=53ef14e41508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ef14e41508, replyNumber=0, likeNumber=67, createdTime=2018-08-27, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ef14e41508, moduleTitle=未过一致性评价均不再采购千家药企受影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53ef14e41508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444422, encodeId=e855144442231, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=未通过一致性评价不再采购！国家为何这么做, objectType=article, longId=147331, objectId=4f4c14e33149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f4c14e33149, replyNumber=0, likeNumber=63, createdTime=2018-08-25, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f4c14e33149, moduleTitle=未通过一致性评价不再采购！国家为何这么做, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f4c14e33149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444421, encodeId=21961444421a5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=又一省发文，未过一致性评价，暂停挂网, objectType=article, longId=147293, objectId=b7d014e29386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7d014e29386, replyNumber=0, likeNumber=18, createdTime=2018-08-25, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7d014e29386, moduleTitle=又一省发文，未过一致性评价，暂停挂网, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7d014e29386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444420, encodeId=21b514444202a, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=J Rheumatol：使用已验证指标衡量疾病活动性和损伤：系统性红斑狼疮死亡率和损伤的系统评价, objectType=article, longId=147094, objectId=c14d14e094cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14d14e094cf, replyNumber=0, likeNumber=54, createdTime=2018-08-22, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14d14e094cf, moduleTitle=J Rheumatol：使用已验证指标衡量疾病活动性和损伤：系统性红斑狼疮死亡率和损伤的系统评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14d14e094cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444419, encodeId=b79e144441985, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=J Clin Periodontol: ：无创超声实时评价种植体周围组织, objectType=article, longId=147037, objectId=e80714e03712, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e80714e03712, replyNumber=0, likeNumber=61, createdTime=2018-08-21, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e80714e03712, moduleTitle=J Clin Periodontol: ：无创超声实时评价种植体周围组织, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e80714e03712)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444418, encodeId=1c051444418d3, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Anesth Analg：剖宫产术后椎管内阿片类药物吗啡的使用与呼吸抑制发生率的关系：系统性评价, objectType=article, longId=146474, objectId=e9041464e437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9041464e437, replyNumber=0, likeNumber=17, createdTime=2018-08-14, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9041464e437, moduleTitle=Anesth Analg：剖宫产术后椎管内阿片类药物吗啡的使用与呼吸抑制发生率的关系：系统性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9041464e437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444417, encodeId=e01a144441e94, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=腹主动脉腔内修复手术质量评价指标体系的中国专家共识, objectType=article, longId=146369, objectId=9d9f14636947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d9f14636947, replyNumber=0, likeNumber=15, createdTime=2018-08-12, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d9f14636947, moduleTitle=腹主动脉腔内修复手术质量评价指标体系的中国专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d9f14636947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444416, encodeId=57a8144441686, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=抗体偶联药物质量控制和临床前评价专家共识, objectType=article, longId=146298, objectId=74c514629897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74c514629897, replyNumber=0, likeNumber=19, createdTime=2018-08-11, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74c514629897, moduleTitle=抗体偶联药物质量控制和临床前评价专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74c514629897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444415, encodeId=140f1444415f9, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=中国胸主动脉腔内修复手术质量评价标准出台：30天死亡率是结局指标, objectType=article, longId=146186, objectId=cd6814618615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd6814618615, replyNumber=0, likeNumber=61, createdTime=2018-08-10, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd6814618615, moduleTitle=中国胸主动脉腔内修复手术质量评价标准出台：30天死亡率是结局指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd6814618615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444414, encodeId=95f6144441487, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=CHC2018丨支架贴壁不良的腔内影像学评价, objectType=article, longId=146034, objectId=67ae146034b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67ae146034b0, replyNumber=0, likeNumber=61, createdTime=2018-08-08, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67ae146034b0, moduleTitle=CHC2018丨支架贴壁不良的腔内影像学评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67ae146034b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444413, encodeId=941a1444413a3, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=综合监管制度政策解读和评价, objectType=article, longId=145922, objectId=370b145922de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=370b145922de, replyNumber=0, likeNumber=31, createdTime=2018-08-06, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=370b145922de, moduleTitle=综合监管制度政策解读和评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=370b145922de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

评价

2020-05-29

huagfeg (审核中...)

前往app查看评论内容

#评价#

JAHA：轻度肺动脉高压与死亡率升高相关：系统评价和meta分析

2018-09-21

huagfeg (审核中...)

前往app查看评论内容

#评价#

关于非临床安全评价中药物未出现明显毒性的考虑

2018-09-12

huagfeg (审核中...)

前往app查看评论内容

#评价#

又有7个药通过一致性评价，大洗牌来了

2018-09-11

huagfeg (审核中...)

前往app查看评论内容

#评价#

基药目录调入调出仿制药直面一致性评价大洗牌

2018-09-09

huagfeg (审核中...)

前往app查看评论内容

#评价#

定了！289品种年底未通过一致性评价直接淘汰！

2018-09-07

huagfeg (审核中...)

前往app查看评论内容

#评价#

一致性评价后医药市场格局

2018-09-05

huagfeg (审核中...)

前往app查看评论内容

#评价#

重磅！《医疗器械不良事件监测和再评价管理办法》发布

2018-09-02

huagfeg (审核中...)

前往app查看评论内容

#评价#

又一省，一致性评价药品特权落地

2018-08-31

huagfeg (审核中...)

前往app查看评论内容

#评价#

又一省一致性评价药品特权落地

2018-08-31

huagfeg (审核中...)

前往app查看评论内容

#评价#

未过一致性评价均不再采购千家药企受影响

2018-08-27

huagfeg (审核中...)

前往app查看评论内容

#评价#

未通过一致性评价不再采购！国家为何这么做

2018-08-25

huagfeg (审核中...)

前往app查看评论内容

#评价#

又一省发文，未过一致性评价，暂停挂网

2018-08-25

huagfeg (审核中...)

前往app查看评论内容

#评价#

J Rheumatol：使用已验证指标衡量疾病活动性和损伤：系统性红斑狼疮死亡率和损伤的系统评价

2018-08-22

huagfeg (审核中...)

前往app查看评论内容

#评价#

J Clin Periodontol: ：无创超声实时评价种植体周围组织

2018-08-21

huagfeg (审核中...)

前往app查看评论内容

#评价#

Anesth Analg：剖宫产术后椎管内阿片类药物吗啡的使用与呼吸抑制发生率的关系：系统性评价

2018-08-14

huagfeg (审核中...)

前往app查看评论内容

#评价#

腹主动脉腔内修复手术质量评价指标体系的中国专家共识

2018-08-12

huagfeg (审核中...)

前往app查看评论内容

#评价#

抗体偶联药物质量控制和临床前评价专家共识

2018-08-11

huagfeg (审核中...)

前往app查看评论内容

#评价#

中国胸主动脉腔内修复手术质量评价标准出台：30天死亡率是结局指标

2018-08-10

huagfeg (审核中...)

前往app查看评论内容

#评价#

CHC2018丨支架贴壁不良的腔内影像学评价

2018-08-08

huagfeg (审核中...)

前往app查看评论内容

#评价#

综合监管制度政策解读和评价

2018-08-06

科室
- - 订阅+
  - 更多科室
工具
服务